4v0g: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 4v0g is ON HOLD | The entry 4v0g is ON HOLD until Paper Publication | ||
Authors: Debreczeni, J.E., Hennessy, E.J., Chuaquini, C., Ashton, S., Coclough, N., Cross, D.A.E., Eberlein, C., Gingipalli, L., Klinowska, T.C.M., Orme, J.P., Sha, L., Wu, X. | Authors: Debreczeni, J.E., Hennessy, E.J., Chuaquini, C., Ashton, S., Coclough, N., Cross, D.A.E., Eberlein, C., Gingipalli, L., Klinowska, T.C.M., Orme, J.P., Sha, L., Wu, X. | ||
Revision as of 10:53, 30 April 2015
Unreleased structure
The entry 4v0g is ON HOLD until Paper Publication
Authors: Debreczeni, J.E., Hennessy, E.J., Chuaquini, C., Ashton, S., Coclough, N., Cross, D.A.E., Eberlein, C., Gingipalli, L., Klinowska, T.C.M., Orme, J.P., Sha, L., Wu, X.
Description: JAK3 in complex with a covalent EGFR inhibitor